Transitioning to early, multi-disease co-governance strategies is essential for managing aortic valve calcification and metabolic disease effectively.
Absolute Event Rate: 0% vs 0%
Future management strategies must transition toward early, multi-disease co-governance strategies. At the same time, targeted drugs will be developed for specific pathways on this axis, surpassing the current treatment status of relying solely on valve replacement surgery.
Wang et al. (Wed,) reported a other. Transitioning to early, multi-disease co-governance strategies is essential for managing aortic valve calcification and metabolic disease effectively.